Wednesday, 14 October 2026European Markets

ROULARTA And NRJ GROUP Have A High Dividend Yield And Return On Equity In The Communication Services Sector.

Loading stream...

(vianews) - roularta (rou.br) is among this list of stock assets with the highest dividend rate and return on equity on the communication services sector.

financial asset price forward dividend yield return on equity
roularta (rou.br) €10.80 9.3% 1.07%
nrj group (nrg.pa) €7.86 4.22% 6.55%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. roularta (rou.br)

9.3% forward dividend yield and 1.07% return on equity

roularta media group nv operates as a multimedia company in belgium, the netherlands, and germany. the company operates in two segments, media brands and printing services. it offers general news, weekly, business news, sports news, lifestyle, tv, professional, and medical magazines; and regional papers, business newspapers, sunday papers, and digital solutions, as well as operates news and business television. the company also provides recruitment solutions; real estate, printing, and business information services; events, fairs, and networking services; line extensions and rights; and advertising services. in addition, it operates internet platform and brand studio, as well as engages in subscriptions and sales of the newsstand. the company was founded in 1954 and is headquartered in roeselare, belgium. roularta media group nv is a subsidiary of koinon nv.

earnings per share

as for profitability, roularta has a trailing twelve months eps of €0.2.

pe ratio

roularta has a trailing twelve months price to earnings ratio of 54. meaning, the purchaser of the share is investing €54 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.07%.

moving average

roularta's value is higher than its 50-day moving average of €10.73 and below its 200-day moving average of €11.92.

sales growth

roularta's sales growth for the current quarter is 8.5%.

yearly top and bottom value

roularta's stock is valued at €10.80 at 12:30 est, way under its 52-week high of €17.15 and higher than its 52-week low of €10.00.

more news about roularta.

2. nrj group (nrg.pa)

4.22% forward dividend yield and 6.55% return on equity

nrj group sa, a private media company, operates as a publisher, producer, and broadcaster in france and internationally. it operates 4 radio stations under the nrj, cherie fm, nostalgie, and rire & chansons brands; approximately 230 digital radios; 6 websites; and 7 mobile applications, as well as a replay tv. the company also operates two national channels, which include nrj 12 and cherie 25; and nrj hits, a music channel for cable satellite. in addition, it engages in advertising activities; marketing activities; operates musical shows under the nrj music label; and audio and audio visual, trademark licensing, and real estate activities. nrj group sa was founded in 1981 and is based in paris, france.

earnings per share

as for profitability, nrj group has a trailing twelve months eps of €0.48.

pe ratio

nrj group has a trailing twelve months price to earnings ratio of 16.38. meaning, the purchaser of the share is investing €16.38 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.55%.

revenue growth

year-on-year quarterly revenue growth grew by 5.2%, now sitting on 409.24m for the twelve trailing months.

more news about nrj group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com